IP Library Granted Patent US 8,188,076
Granted Patent B2
US 8,188,076 · App. 12/714,406 · Granted May 29, 2012

Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,188,076
App. No.
12/714,406
Granted
May 29, 2012
Kind
B2
Abstract

The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.

Claims (8)

1. A compound having the structure of Compound 14b, or a pharmaceutically acceptable salt thereof:

2. The compound of claim 1 , wherein the compound is in the form of a hydrochloride salt.

3. A compound having the structure of Compound 14b, or a pharmaceutically acceptable salt or isomer thereof:

wherein one or more hydrogens of the compound are optionally substituted with 2 H (deuterium).

4. A pharmaceutical composition comprising the compound according to claim 1 and a pharmaceutically acceptable carrier, excipient, or diluent.

5. A method of treating psychoses, schizophrenia, acute mania, bipolar disorder, autistic disorder or depression, the method comprising administering to a patient in need thereof the pharmaceutical formulation according to claim 4 .

6. The method of claim 5 , wherein said method treats schizophrenia.

7. The method of claim 5 , wherein said method treats bipolar disorder.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2010
From: BHAT, LAXMINARAYAN; MOHAPATRA, PRABHU PRASAD; ADIEY, KOUACOU
To: REVIVA PHARMACEUTICALS, INC.
Reel/Frame 024446/0443 →